Han Sang-chul

Jeil Pharma Holdings CEO · 3 stocks

Value held (filed)$9.3M3 direct holdings

30-day netNo change

Holdings

Value Stake Latest filing

Onconic Therapeuticsdirect 0.05% · indirect 2.61%2.66%$11M

Direct0.05%
Jeil Pharma Holdings 10.64% → Jeil Pharmaceutical 49.24% → Onconic Therapeutics 44.56%2.33%
Jeil Pharmaceutical 0.61% → Onconic Therapeutics 44.56%0.27%

Jeil Pharma Holdingsdirect 10.64%10.64%$8.6M

Jeil Pharmaceuticaldirect 0.61% · indirect 5.24%5.85%$5.5M

Direct0.61%
Jeil Pharma Holdings 10.64% → Jeil Pharmaceutical 49.24%5.24%

Indirect stakes multiply ownership through listed companies. Stakes through unlisted companies and holdings under 5% are not filed. Values overlap through subsidiaries, so do not add them up.